King Wealth Nevro Corp Transaction History

King Wealth

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$14.18 - $22.31 $141,800 - $223,100	-10,000 Reduced 49.5%	10,200 $220,000
Q2 2023 Aug 10, 2023	BUY	$22.62 - $39.32 $158,340 - $275,240	7,000 Added 53.03%	20,200 $513,000
Q1 2023 May 10, 2023	SELL	$30.17 - $41.11 $265,496 - $361,768	-8,800 Reduced 40.0%	13,200 $477,000
Q3 2022 Nov 10, 2022	SELL	$40.66 - $53.03 $203,299 - $265,150	-5,000 Reduced 18.52%	22,000 $1.03 Million
Q2 2022 Aug 11, 2022	BUY	$40.85 - $77.67 $245,100 - $466,020	6,000 Added 28.57%	27,000 $1.18 Million
Q1 2022 May 12, 2022	BUY	$59.95 - $92.06 $1.26 Million - $1.93 Million	21,000 New	21,000 $1.52 Million
Q1 2019 May 13, 2019	SELL	$35.52 - $62.62 $191,808 - $338,148	-5,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $65,545 - $104,136	1,850 Added 52.11%	5,400 $210,000
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $156,981 - $267,918	3,550 New	3,550 $202,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.